Changes in end systolic volume and ejection fraction 90 days after treatment
| End systolic volume (ml/m2) | Ejection fraction (%) | |||||||
|---|---|---|---|---|---|---|---|---|
| Group A (captopril) |
Group B (captopril + losartan) | Group C (losartan) | Group A (captopril) |
Group B (captopril + losartan) | Group C (losartan) | |||
| 3 days | 46.2 (14) | 45.9 (13) | 45.7 (12) | 47.3 (11) | 46.5 (10) | 47.6 (12) | ||
| 7–10 days | 45.5 (9.5) | 43.6 (10) | 46.8 (12) | 47.9 (8.1) | 49.1 (6.1) | 47.2 (10) | ||
| 90 days | 48.8 (9)‡ | 44.6 (8)† ‡ | 50.3 (13)† | 48.4 (9) | 50.8 (7)* | 46.4 (12)* | ||
| p Value | NS | NS | NS | NS | NS | NS | ||
End systolic volume †p = 0.023; ‡p = 0.016.
Ejection fraction *p = 0.054.